Patient engagement diversity strategy in clinical trials
patient engagement diversity strategy

Client:  Top 20 biopharmaceutical company

Indication:  Sickle cell disease

Case Study

How COUCH Health supported the diversity strategy of a global phase III study

Inclusive patient recruitment materials

Cultural competency training

Enlightening patient insights

Improved clinical trial diversity

Challenge

A top 20 biopharma company needed to improve their diversity and inclusion strategy. The aim was to ensure recruited participants were more representative of the sickle cell population.

Approach

To understand why the intended treatment population hadn’t been sufficiently represented previously, three clear barriers were identified through an audit:

Inadequate cultural competency training amongst site staff

1

Linguistic barriers

2

No translations of investigator site support materials

3

Based on these insights, an online cultural competency training programme was developed, accessed through live virtual meetings and on-demand learning modules, along with a diversity guide. Investigator site recruitment materials were tailored to be inclusive and translated into relevant languages.

Results

At sites where cultural competency training was implemented and updated investigator site support materials used, more minority patients were successfully recruited.

 

The sites that weren’t previously recruiting minorities improved their diversification by 39% within three months of completing the training.

Explore how you could benefit from our diversity strategy solutions by getting in touch

COUCH Health patient engagement agency

About

Services

Sectors

  • COUCH Health Patient engagement agency linkedin
  • COUCH Health Patient engagement agency instagram
  • COUCH Health Patient engagement agency twitter

© 2020 We are Couch LTD. All rights reserved.  Privacy PolicySubmit your RFP.